Immuneering Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

Immuneering Corp reported Cash And Cash Equivalents At Carrying Value of $128.65 million for the year ending 2025.

  • Immuneering Corp showed an increase of +255.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Immuneering Corp's annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Immuneering Corp's Cash And Cash Equivalents At Carrying Value has grown by 246.8%.
  • Historical annual values: Fiscal year 2025: $128.65 million | Fiscal year 2024: $36.14 million | Fiscal year 2023: $59.41 million | Fiscal year 2022: $72.64 million | Fiscal year 2021: $74.89 million | Fiscal year 2020: $37.09 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: